Sign up for free insights newsletter
30

Sino BiologicalInc.

301047SHE

Need professional-grade analysis? Visit stockanalysis.com

CN¥75.25
+0.03%
End of day
Market Cap

$9.12B

P/E Ratio

61.96

Employees

1,021

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino19.7621.04-0.330.461.934.82
Calmar-0.440.471.900.84
Sharpe4.457.93-0.240.271.071.74
Omega4.122.760.971.091.241.54
Martin-0.760.813.991.74
Ulcer0.090.647.779.607.956.86

Sino BiologicalInc. (301047) Price Performance

Sino BiologicalInc. (301047) trades on SHE in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY75.25, up 0.03% from the previous close.

Over the past year, 301047 has traded between a low of CNY56.11 and a high of CNY82.02. The stock has gained 30.7% over this period. It is currently 8.3% below its 52-week high.

Sino BiologicalInc. has a market capitalization of $9.12B, with a price-to-earnings ratio of 61.96.

About Sino BiologicalInc.

Sino Biological,Inc. provides recombinant protein and antibody reagents for life science researchers in China and internationally. The company offers recombinant proteins, antibodies, cDNA clones, kits, serum-free media, protein modification, qPCR primers, cell lysates, and purification reagents. It also provides comprehensive solutions, including autoimmune disease research, kinase drug discovery, cytokine and growth factor, SARS-CoV-2 variants research, comprehensive CAR-T therapy, 3D organoids research, ADC development, influenza vaccine development, and multispecific antibody development solutions, as well as solutions for MSCs therapy and in vitro efficacy evaluation. It serves academic research institutions, biotech companies, and pharmaceutical companies. Sino Biological,Inc. was founded in 2016 and is headquartered in Beijing, China.

Compare Sino BiologicalInc.

Side-by-side comparison against top Healthcare peers.

Company Info

Exchange
SHE
Currency
CNY
Country
China

Financial Metrics

Revenue (TTM)
$660.17M
EBITDA
$131.77M
Profit Margin
20.12%
EPS (TTM)
1.21
Book Value
43.38

Technical Indicators

52 Week High
CN¥85.00
52 Week Low
CN¥55.76
50 Day MA
CN¥72.32
200 Day MA
CN¥73.02
Beta
0.91

Valuation

Trailing P/E
61.96
Forward P/E
57.14
Price/Sales
13.81
Price/Book
1.72
Enterprise Value
$5.98B